Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction

NCT02442492 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Trial terminated following Dutch DSMB recommendation for their Study

Conditions

Intrauterine Growth Restriction (IUGR)
Fetal Growth Restriction (FGR)

Interventions

DRUG: Sildenafil
DRUG: Placebo

Sponsor

University of British Columbia